Types of articles
Mathews Open Access Journals committed to publish quality and valuable scientific contributions like Original Article, Research article, Review Articles, Mini-reviews, Case report, Editorial, Commentary, Letter to the Editor, Short reports and Opinion articles.
Format of articles
In most of the cases, we do not impose strict limits on word count or page number. Yet, we strongly recommend that you write concisely and stick to the following instructions:
Title page should contain title, running title, author affiliations, and contact information by differentiating the corresponding author with an asterisk. Also should include word count, number of tables and figures, sources of support, source of funding, any disclaimers, and conflict of interest declarations.
The abstract is mandatory for original research, review article, short reviews, and case reports. It should contain the background of the study, should state the study's purpose, basic procedures, main findings, and principal conclusions. It is advised to highlight the novel and significant aspects of the study.
Three to six key words are mandatory that should explain the research.
All the abbreviations that are used in the article should be listed.
The introduction should provide the background and purpose of the study. It should state the research objectives, hypothesis of the study or the observation. The content in the introduction should be cited properly using more recent references. Avoid providing unrelated information.
Materials and Methods
This section should contain adequate and detailed information of all the procedures and steps. It can be divided into subsections if several methods are described. Standard protocols should be credited with appropriate references.
A clear presentation of experimental results obtained, highlighting any trends or points of interest. The results presented in tables and figures should be placed in close proximity to the text describing them in order to improve the accessibility of the data. The results should not be repeated in both tables and figures.
The discussion should relate to the significance of the observations. Briefly summarizing the main findings, then explore possible mechanisms or explanations for these findings, compare and contrast the results with other relevant studies, state the limitations of the study, and explore the implications of the findings for future research and for clinical practice.
It should be crisp and clear with a logical conclusion, interpretation and data generation from the experimental study.
References (limited to 60 references, though not strictly enforced)
References should follow the standards summarized in the NLM's International Committee of Medical Journal Editors (ICMJE) Recommendations. All references cited in the text must be included in the reference list and vice versa. All references must be numbered consecutively and citations of references in text should be identified using numbers in square brackets (e.g., “as discussed by Smith A, et al. ”; “as discussed elsewhere [9, 10]”). All references should be cited within the text; otherwise, these references will be automatically removed.
Author contributions (names must be given as initials)
Additional Information (including a Competing Interests Statement)
Figure legends (these are limited to 350 words per figure)
Tables (maximum size of one page)
In the cover letter, one must include:
Published : 18th September 2019
Authors : Yutian Sun1, Hong Gao1, Boqi Hu2
Citation : Hu B. (2019). Multimodality Evaluation of Multiple Mitral Valve Myxomas: A Rare, Benign but Potentially Life-Threatening Tumor. Mathews J Cardiol 4(1): 21.
Published : 03rd March 2019
Author : Yasser Mohammed Hassanain Elsayed*
Citation : Elsayed YMH (2019). Test the Vasospastic ST-Segment Depression Reversibility with Nitrates in Non-Obstructive Coronary Disease. Mathews J Cardiol 4(1): 20.
Published : 15th November 2018
Authors : Osmar Antonio Centurión1,2*, FACC, FAHA, José Fernando Alderete1 , Judith María Torales1,2, Laura Beatriz García1,2, Karina Elizabeth Scavenius1
Citation : Centaurión OA, Alderete JF, Morales JM, Garcían LB, et al. (2018). Augmented Atrial Vulnerability in Patients with Sinus Node 3 Dysfunction: Is the Electrophysiologic Abnormality Limited Only to the Sinus Node?. Mathews J Cardiol. 3(1): 019.
Published : 14th November 2018
Authors : Luca Anfuso1 , Massimo Corsi1 , Antonio Fasano1,2
Citation : Anfuso L, Corsi M and Fasano A. (2018). Esophageal Thermal Probes: How Fast Should They Be?. Mathews J Cardiol. 3(1): 018.
Published : 25th September 2018
Authors : Osmar Antonio Centurión1,2, Christian O. Chávez-Alfonso1 , Laura Beatriz García1,2, Judith María Torales1,2
Citation : Centurión OA, Chávez-Alfonso C, García LB and Torales JM. (2018). Influence of Serum Biomarkers in the Diagnostic, Prog- 5 nostic and Therapeutic Management of Patients with Heart Failure Mathews J Cardiol. 3(1): 017..
Published : 19th September 2018
Authors : Maurizio Santomauro1 , Raffaele Giordano1 , Giuseppe Comentale1 , Carla Riganti2 , Mario Petretta3 , Domenico Bonaduce3 , Emanuele Pilato1 , Vincenzo De Amicis1 , Gabriele Iannelli1
Citation : Santomauro M, Giordano R, Comentale G, Riganti C, et al. (2018). Comparison of the Implantable Cardiac Monitor Reveal LINQ Versus Reveal XT in Young Patients. Mathews J Cardiol. 3(1): 016.
Published : 21st September 2017
Authors : Nejeh Ben Halima1 , Yosra Messaoudi1 , Ahmed Sghaier1 *, Houssem Thabet1, Afef Lagren1, Essia Boughzela2
Citation : Sghaier A, Halima NB, Messaoudi Y, Thabet H. (2017). Percutaneous Closure of Adult Atrial Septal Defects in Adults: Short- 6 and Medium-Term Results. Mathews J Cardiol. 2(2): 015.
Published : 02nd August 2017
Authors : Osmar Antonio Centurión1,2, Juan D. Cáceres1
Citation : Centurión OA and Cáceres JD. (2017). Red blood cell transfusion in open heart surgery: Are we all ready for bloodless medi- 3 cine and surgery? Mathews J Cardiol. 2(2): 014.
Published : 17th July 2017
Authors : Osmar Antonio Centurión1,2, and Juan D. Cáceres1
Citation : Centurión OA and Cáceres JD. (2017). The Cardiovascular Protective Effects of Erythropoietin Stimulating Agents. Mathews J Cardiol. 3 2(2): e002.
Subscribe to our RSS feed, be in touch with our articles, news, videos, reebies.